Metraipolis › archive › dc_105fee602f85
Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a… — Europe PMC PMID:41175237
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41175237
- DOI
- 10.1007/s00432-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T20:50:12.298Z
- SHA-256 of the archived text
185c406b80516f2605864d8091e69cc4576d8ce2095b55e9df9098b73b5bdf41- Stable URL of this page
https://metraipolis.com/documento/dc_105fee602f85
How to cite
Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a… — Europe PMC PMID:41175237 — Europe PMC (en), https://europepmc.org/article/MED/41175237 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_105fee602f85 (Metraipolis archive dc_105fee602f85, sha256 185c406b80516f2605864d8091e69cc4576d8ce2095b55e9df9098b73b5bdf41)
BibTeX
@misc{dc105fee602f85,
title = {Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a… — Europe PMC PMID:41175237},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41175237},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_105fee602f85; sha256 185c406b80516f2605864d8091e69cc4576d8ce2095b55e9df9098b73b5bdf41},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41175237. Agents can read the archived copy with the MCP tool read_document.